Cas:62015-39-8 methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate manufacturer & supplier

We serve Chemical Name:methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate CAS:62015-39-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate

Chemical Name:methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate
CAS.NO:62015-39-8
Synonyms:Misopess;Misoprostolum;Misoprostolum [INN-Latin];Isprelor;Cytotec;Misotol;GyMiso;Arthrotec
Molecular Formula:C22H38O5
Molecular Weight:382.53400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:83.83000
Exact Mass:382.27200
LogP:3.95360

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Misopess chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Arthrotec physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cytotec Use and application,Misoprostolum technical grade,usp/ep/jp grade.


Related News: The majority of adults with lupus have increased type I interferon signalling, which is known to be associated with disease activity and severity. ethyl 2-cyano-1-oxo-3-(pyridin-3-yl)-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carboxylate manufacturers Cholesterol drug Crestor, blood thinner Brilinta and acid reflux med Nexium have all suffered as a result. Brilinta, for example, saw emerging markets sales drop 40% at constant currencies to $180 million in the first six months of 2021. 2-ethenyl-2-phenyloxirane suppliers For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. 3-[3-[4-(hexadecanoylamino)phenyl]-5-oxo-4H-pyrazol-1-yl]benzenesulfonic acid vendor & factory.